Topline Capital Management’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-41,764
Closed -$7.14M – 44
2026
Q2
$7.14M Sell
41,764
-136,036
-77% -$17.2M 1.85% 12
2026
Q1
$16.9M Sell
177,800
-497,694
-74% -$61M 2.79% 12
2025
Q4
$111M Buy
675,494
+118,927
+21% +$15.8M 10.06% 2
2025
Q3
$57.5M Buy
556,567
+247,436
+80% +$24.3M 9.89% 3
2025
Q2
$38.5M Buy
309,131
+129,418
+72% +$16.7M 6.6% 6
2025
Q1
$8.45M Buy
179,713
+173
+0.1% +$8.44K 1.93% 14
2024
Q4
$5.69M Buy
+179,540
New +$5.12M 1.08% 18

Other funds holding NUTX

Topline Capital Management's NUTX Position: Q3 2026 in Review

Topline Capital Management sold out of Nutex Health (NUTX) in Q3 2026, closing a stake of 41,764 shares — an estimated $7.14M sold.

Topline Capital Management first reported a position in NUTX in Q4 2024 and held it in 7 quarters. The position peaked at $111M in Q4 2025. 184 funds tracked by Wall St. Rank hold NUTX as of Q3 2026.

  • Topline Capital Management reported no remaining Nutex Health position as of Q3 2026 after selling out during the quarter.
  • Topline Capital Management sold 41,764 Nutex Health shares in Q3 2026, an estimated $7.14M.
  • Topline Capital Management first reported a position in Nutex Health in Q4 2024 and held it in 7 quarters.
  • Topline Capital Management's Nutex Health position peaked at $111M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Nutex Health as of Q3 2026.

Based on Topline Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.